首页 斯达外科手术(usSTAA)-基本信息

斯达外科手术(usSTAA)-基本信息

日报更新时间:

周报更新时间:04-18 04:06

行情信息

今开价:128.82

最高价:131.52

成交量:890416.0

昨收价:128.84

最低价:126.61

最新价:130.15

行情图标
概要信息

中文名称:斯达外科手术


英文名称:Staar Surgical


行业:服务业


简介:Staar Surgical Company设计、开发、制造并售卖可植入镜头


电话:1-626-3037902


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

STAAR Surgical Company连同旗下子公司设计、开发、生产和销售用于眼部的植入性镜片及植入镜片至眼睛的激光系统,STAAR Surgical公司提供:1、Visian——植入性隐形镜片(ICL),治疗视力障碍,如近视,远视,散光,老花;远视植入性隐形镜片(ICL),治疗远视。2、提供微创人工晶体(IOL),其中包括折叠式人工晶体,用于微创白内障手术;非球面人工晶体,可呈现比传统球面镜片更清晰的图像;nanoFLEX人工晶体,一种单片的非球面隐形镜片;环面人工晶体,提供白内障患者及使用于白内障手术中的预载注射器。3、此外,STAAR Surgical Company销售外科产品,其他相关仪器和设备,注射器零组件及制造用于治疗青光眼的AquaFlow设备。STAAR Surgical Company以STAAR®、EVO Visian ICL、Evolution in Visual Freedom、Visian、Collamer、CentraFLOW、AquaPORT、nanoFLEX、nanoPOINT 和 Afinity品牌(商标)销售其产品给医疗照护公司,包括手术中心、医院、管理式照护服务提供商、医疗机构、集体采购组织及政府机构。STAAR Surgical Company通过其在美国,日本,西班牙,德国,加拿大,英国和新加坡的销售代表直接销售产品,并通过约75个国家的独立分销商销售产品。斯达外科手术STAAR Surgical Company(STAA)历史百科:STAAR®为白内障手术开发,获得专利并获得第一个折叠式人工晶状体(IOL)的许可。由可弯曲材料制成的可折叠人工晶状体首次允许外科医生用微创手术取代白内障患者的天然晶状体。可折叠人工晶体成为全世界白内障手术的标准护理。1991年,STAAR推出了第一个由硅胶制成的隐形眼镜。1996年,STAAR开始在美国以外销售VisianICL®。由STAAR专有的生物相容性Collamer®晶状体材料制成的ICL植入虹膜后面和患者天然晶状体前面,以治疗屈光不正,如近视,远视和散光。ICL于1997年获得CE认证,允许在需要欧盟CE标志的国家销售,并于2005年12月获得美国FDA批准用于治疗近视。STAAR在60多个国家销售EVO Visian ICL和Visian ICL系列隐形眼镜,并已被全球超过80万客户使用。

交易日期 交易人 职位 类型 交易份额 价格
2019-06-19 Wall (William P) Director Buy 4254 --
2019-06-19 Silverman (Louis) Director Buy 2127 --
2019-06-19 Moore (John C) Director Buy 4254 --
2019-05-05 Moore (John C) Director Buy 7500 1.92
2019-05-02 BROADWOOD PARTNERS L P Beneficial Owner of More than 10% Class Buy 100000 22.23
2019-04-03 Andrews (Deborah J) Chief Financial Officer Sell 1000 34.35
2019-03-21 Holliday (Keith Ph.D.) Chief Technology Officer Sell 3125 38.89
2019-03-21 Gesten (Samuel J) Officer Sell 1688 38.87
2019-03-21 Andrews (Deborah J) Chief Financial Officer Sell 833 38.88
2019-03-18 Mason (Caren L) Chief Executive Officer Sell 7500 36.25
2019-03-18 Gesten (Samuel J) Officer Sell 1500 36.20
2019-03-18 Holliday (Keith Ph.D.) Chief Technology Officer Sell 2084 36.22
2018-09-30 BROADWOOD PARTNERS L P Beneficial Owner of More than 10% Class Sell 114549 --
2018-08-19 Wall (William P) Director Sell 5000 41.35
2018-06-13 Moore (John C) Director Buy 3691 --
2018-06-13 Farrell (Stephen C) Director Buy 3691 --
2018-06-13 Wall (William P) Director Buy 3691 --
2018-05-06 Andrews (Deborah J) Chief Financial Officer Buy 25000 5.68
2018-05-02 Andrews (Deborah J) Chief Financial Officer Sell 13331 17.60
2018-05-02 Andrews (Deborah J) Chief Financial Officer Buy 13331 2.91
2018-03-21 Holliday (Keith Ph.D.) Chief Technology Officer Sell 2188 16.03
2018-03-21 Andrews (Deborah J) Chief Financial Officer Sell 333 16.05
2018-03-21 Gesten (Samuel J) Officer Sell 2833 16.05
2018-03-19 Holliday (Keith Ph.D.) Chief Technology Officer Sell 1458 16.05
2018-03-18 Mason (Caren L) Chief Executive Officer Sell 6667 16.09

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
SSGA Funds Management Inc 404293 0.91% -- -- 2019-07-31
State Street Corporation 1136094 2.55% 86296 8.22% 2019-03-31
Vanguard Investments Australia Ltd 1233916 2.77% 102 0.01% 2019-07-31
BlackRock Fund Advisors 1570679 3.53% -101092 -6.05% 2019-07-31
Baillie Gifford & Co Limited. 1774201 3.99% 68680 4.03% 2019-03-31
BlackRock Inc 2960201 6.66% -150884 -4.85% 2019-03-31
Vanguard Group Inc 3628164 8.16% 28259 0.78% 2019-03-31
Palo Alto Investors, LLC 4218902 9.49% 70914 1.71% 2019-03-31
BROADWOOD CAPITAL Inc 10740630 24.15% -- -- 2019-03-31
Northern Trust Investments Inc 831109 1.87% 10949 1.33% 2019-07-31
Waddell & Reed Financial Inc 773868 1.74% 773868 -- 2019-03-31
Waddell & Reed Investment Management Co 773868 1.74% 773868 -- 2019-03-31
TIAA-CREF Investment Management LLC 408304 0.92% 42610 11.65% 2019-03-31
State Street Global Advisors 417155 0.94% 300 0.07% 2019-07-31
Geode Capital Management, LLC 445561 1.00% -370273 -45.39% 2019-03-31
Goldman Sachs Group Inc 455189 1.02% 214497 89.12% 2019-03-31
Bridger Management LLC 514105 1.16% -- -- 2019-03-31
Northern Trust Investments N A 533516 1.20% 2739 0.52% 2019-03-31
Northern Trust Corp 533516 1.20% 2739 0.52% 2019-03-31
Renaissance Technologies Corp 745900 1.68% -529900 -41.53% 2019-03-31
Marshall Wace Asset Management Ltd 403060 0.91% 250893 164.88% 2019-03-31
BlackRock Asset Management Canada Ltd 973940 2.19% -720 -0.07% 2019-05-31
Millennium Management LLC 494011 1.11% -388482 -44.02% 2018-12-31
Deutsche Bank AG 384631 0.87% 14736 3.98% 2018-12-31
Fidelity Management & Research Company 388221 0.87% 22581 6.18% 2019-04-30
Two Sigma Investments LLC 393603 0.89% 70510 21.82% 2018-12-31
Schonfeld Strategic Advisors LLC 380946 0.86% 38246 11.16% 2018-12-31
Fuller & Thaler Asset Management Inc 361771 0.82% -30178 -7.70% 2018-12-31
Marshall Wace North America LP 507072 1.15% 507072 -- 2018-09-30
Amvescap Plc. 325004 0.74% 183849 130.25% 2018-09-30
Putnam Investments LLC 480238 1.09% -2018632 -80.78% 2018-09-30
Putnam Investment Management, LLC 480238 1.09% -2018632 -80.78% 2019-01-31
D. E. Shaw & Co LP 411400 0.93% 327625 391.08% 2018-06-30
BlackRock Institutional Trust Company NA 1002389 2.27% -73883 -6.86% 2018-06-30
Putnam Investment Management,LLC 2498870 5.66% -3774269 -60.17% 2018-06-30
Next Century Growth Investors LLC 507871 1.15% 382710 305.77% 2018-06-30
Principal Global Investors, LLC 215081 -- 7051 3.39% 2018-06-30
AQR Capital Management LLC 256131 -- 256131 -- 2018-06-30
State Street Corp 751793 -- 21242 2.91% 2018-06-30
Broadwood Partners LP 10881079 -- 10881079 -- 2018-08-01
Cortina Asset Management LLC 199927 -- -197150 -49.65% 2018-06-30
Oberweis Asset Management Inc 184020 -- 184020 -- 2018-06-30
Grandeur Peak Global Advisors, LLC 183841 -- -8825 -4.58% 2018-06-30
Advisory Research Inc 128322 0.31% 128322 -- 2018-06-30
EAM Investors 128820 0.31% 128820 -- 2018-06-30
King Luther Capital Management Corp 157230 0.38% -6160 -3.77% 2018-06-30
Northern Trust Asset Management 101718 0.24% -245 -0.24% 2018-07-31
BNY Mellon Investment Management 98429 0.24% 1177 1.21% 2018-06-30
Mercer Global Investments Europe Limited 89913 0.21% 6530 7.83% 2018-06-30
Candriam Belgium 93000 0.22% -20000 -17.70% 2018-05-31
Morgan Stanley & Co Inc 144809 0.35% -17243 -10.64% 2018-03-31
Rice Hall James & Associates, LLC 157759 0.38% -7336 -4.44% 2017-12-31
TIVERTON ASSET MANAGEMENT LLC 137273 0.33% -- -- 2018-03-31
Millrace Asset Group Inc 122767 0.30% 122767 -- 2017-09-30
Menta Capital LLC 203634 0.49% -2687 -1.30% 2017-09-30
Columbia Mangmt Investment Advisers, LLC 1232843 3.09% 1232843 -- 2015-12-31
Morgan Stanley Smith Barney LLC 329655 0.81% -266441 -44.70% 2016-09-30
Archon Capital Management LLC 299790 0.74% -52910 -15.00% 2016-09-30
BlackRock Advisors LLC 158183 0.39% 6880 4.55% 2016-09-30
Coe Capital Management, LLC 130092 0.32% 130092 -- 2016-09-30
Ameriprise Financial,Inc. 2146443 5.00% 18588196 0.10% 1999-11-30
Blackrock,Inc. 2237742 5.00% 19378846 0.10% 1999-11-30
Palo Alto Investors,LLC 3214253 5.00% 27835431 0.10% 1999-11-30
Putnam Investments,LLC 5759039 5.00% 49873278 0.20% 1999-11-30
Broadwood Partners,L.P. 7417582 5.00% 64236260 0.20% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
State Street Russell Small/Mid Cap 188727 0.42% -- -- 2019-07-31
Vanguard Extended Market Index Fund 391870 0.88% -1985 -0.50% 2019-06-30
iShares Russell 2000 Growth ETF 407485 0.91% 4656 1.16% 2019-07-30
Waddell & Reed - Small Cap Grow Sel-UBS 495963 1.11% 495963 -- 2019-03-31
Vanguard Small Cap Index 573852 1.29% -4268 -0.74% 2019-06-30
Baillie Gifford Global Discovery Fund 618958 1.39% -- -- 2019-05-31
Ivy Small Cap Growth Fund 678400 1.52% 314000 86.17% 2019-06-30
iShares Russell 2000 ETF 983838 2.21% 16061 1.66% 2019-07-30
Vanguard Total Stock Market Index Fund 1225644 2.75% 150 0.01% 2019-06-30
SPDR 366942 0.82% -- -- 2019-07-31
Edinburgh Worldwide 360870 0.81% 421 0.12% 2019-04-30
American Funds SMALLCAP World Fund 350800 0.79% 350800 -- 2019-06-30
Vanguard Explorer Fund 201482 0.45% -- -- 2019-03-31
TIAA-CREF Quant Small-Cap Equity Fund 203500 0.46% -- -- 2019-06-30
Vanguard Market Neutral Fund 225012 0.51% -31043 -12.12% 2019-03-31
CREF Stock Account 242614 0.54% -83275 -25.55% 2019-06-30
Vanguard Strategic Small Cap Equity Fund 243240 0.55% -- -- 2019-03-31
Pru Ret Small Cap Growth/TimesSquare SP 260000 0.58% 260000 -- 2019-06-30
AMG TimesSquare Small Cap Growth Fund 260000 0.58% 20000 8.33% 2019-06-30
Vanguard Small Cap Growth Index Fund 330137 0.74% 1159 0.35% 2019-06-30
NT R2000 Growth Index Fund - Non-Lending 185079 0.42% -6223 -3.25% 2019-06-30
Ivy Small Cap Core Fund 216205 0.49% 216205 -- 2019-03-31
iShares US Medical Devices ETF 192636 0.43% -- -- 2019-05-31
iShares US Small Cap ETF (CAD-Hedged) 899222 2.02% -1512 -0.17% 2019-05-30
Vanguard Small Cap Index Fund 579745 1.30% 7950 1.39% 2019-04-30
State Street Russell Small Cap 180731 0.41% 3446 1.94% 2019-02-28
Fidelity 156702 0.35% 24485 18.52% 2019-01-31
Hodges Small Cap Fund 150000 0.34% -50000 -25.00% 2018-12-31
Buffalo Small Cap Fund 136245 0.31% 13600 11.09% 2018-12-31
iShares Micro-Cap ETF 107545 0.24% -- -- 2019-02-28
Principal SmallCap Fund 97800 0.22% 2800 2.95% 2019-01-31
LKCM Small Cap Eq Fund 121390 0.27% -- -- 2018-12-31
Fuller & Thaler Small Cap Core Eq 268870 0.61% 235670 709.85% 2018-12-31
Buffalo Discovery Fund 105120 0.24% 105120 -- 2018-09-30
Putnam Capital Spectrum Fund 180847 0.41% -757712 -80.73% 2018-09-30
Putnam Equity Spectrum Fund 299391 0.68% -1260920 -80.81% 2018-09-30
Artemis US Smaller Companies Fund 164110 0.37% -- -- 2018-09-30
Invesco DWA Healthcare Momentum ETF 117528 0.27% -- -- 2018-12-30
Grandeur Peak Global Opportunities Fund 104122 0.24% 725 0.70% 2018-07-31
X MSCI USA Swap ETF 130672 0.30% 130672 -- 2018-08-31
Fidelity Spartan 124453 0.30% 6983 5.94% 2018-07-31
CREF Stock R1 141400 0.34% -32569 -18.72% 2018-07-31
iShares Micro-Cap 111313 0.26% -- -- 2018-09-12
PowerShares DWA Healthcare Momentum ETF 117666 0.28% -- -- 2018-09-13
Vanguard Extended Market Idx Inv 353026 0.84% 2700 0.77% 2018-07-31
iShares Russell 2000 Growth 398644 0.93% -384 -0.10% 2018-09-12
Vanguard Total Stock Mkt Idx 792595 1.89% -- -- 2018-07-31
Putnam Capital Spectrum A 938559 2.24% -- -- 2018-06-30
LKCM Small Cap Equity Instl 121390 0.29% -- -- 2018-06-30
PowerShares DWA SmallCap Momentum ETF 62676 0.15% -- -- 2018-09-13
Northern Trust Russell 2000 Index Fund - DC - Non-Lending 101718 0.24% -245 -0.24% 2018-07-31
Putnam Equity Spectrum A 1560311 3.73% -3774269 -70.75% 2018-06-30
BlackRock Russell 2000 61419 0.15% 61 0.10% 2018-06-30
AXA 2000 Managed Volatility K 62594 0.15% -- -- 2018-07-31
American Beacon Small Cp Val Inst 65151 0.16% -4047 -5.85% 2018-07-31
Vanguard Health Care ETF 67869 0.16% 576 0.86% 2018-07-31
The Vanguard Russell 2000 Growth Index 74827 0.18% 1233 1.68% 2018-07-31
Schwab Small Cap Index 78000 0.19% -- -- 2018-07-31
Principal SmallCap R2 92800 0.22% 2700 3.00% 2018-07-31
Vanguard Strategic Small-Cap Equity Inv 101397 0.24% 101397 -- 2018-06-30
BlackRock Russell 2500 58010 0.14% 114 0.20% 2018-06-30
Grandeur Peak Global Opportunities Instl 103397 0.25% -74475 -41.87% 2018-04-30
Principal SmallCap SP 54780 0.13% -- -- 2018-05-31
State Street Russell Small/Mid Cap Idx Fd Cl I 129525 0.32% 9068 7.53% 2017-06-30
Vanguard Russell 2000 ETF 45127 0.11% 660 1.48% 2018-05-31
Vanguard Instl Ttl Stk Mkt Idx InstlPls 42792 0.10% -- -- 2018-05-31
TIAA-CREF Small-Cap Blend Idx Inst 48836 0.12% -- -- 2017-11-30
Rice Hall James Micro Cap Instl 43200 0.10% -- -- 2017-11-30
Grandeur Peak Global Reach Instl 57611 0.14% -- -- 2016-10-31
iShares Russell 2000 (AU) 615003 1.60% -774 -0.10% 2015-11-19
Parvest Equity World Health Care 347713 0.90% -15949 -4.40% 2015-09-30
Mutual of America Small Cap Growth Fund 194843 0.50% -- -- 2015-06-30
Vanguard US Discoveries Fund 152640 0.40% -140809 -48.00% 2015-07-31
Vanguard VIF Small Comp Gr 150587 0.40% -- -- 2015-09-30
Columbia Small Cap Core Fund 875052 2.20% -- -- 2015-09-30
Grandeur Peak Global Reach Fund 123875 0.30% -- -- 2015-07-31
Fidelity Spartan® Extended Mkt Indx Fd 105540 0.30% -- -- 2015-09-30
Principal SmallCap Blend SP 137680 0.40% -- -- 2015-10-31

William Walter Goodmen William Walter Goodmen occupies the position of Vice President-Global Human Resources at STAAR Surgical Co. In his past career Mr. Goodmen was EVP-Human Resources & Administration at THQ, Inc., Partner at Center for Corporate Innovation, Inc., Vice President-Business Development at Neovia Integrated Insurance Services, Inc. and Executive Vice President-Human Resources for Liberty Livewire Corp. Mr. Goodmen received an undergraduate degree from Colgate University and a graduate degree from Syracuse University.
Caren L. Mason Caren L. Mason is a businessperson who has been the head of 5 different companies and currently occupies the position of President, Chief Executive Officer & Director at STAAR Surgical Co. Ms. Mason is also on the board of HealthTell, Inc., Advanced Medical Technology Association and Franciscan Sisters of the Poor Foundation, Inc. In the past she occupied the position of President & Chief Executive Officer at Quidel Corp., Senior Vice President-Bayer Corporate Health Care at Bayer AG, Chief Executive Officer & Director at Verinata Health, Inc., Chief Executive Officer at eMed Technologies Corp., President & Chief Executive Officer at MiraMedica, Inc., General Manager for GE Medical Systems Cesk�0�1�0�3 Republika sro and Senior VP-Technical Imaging Business Group at Agfa Corp. Caren L. Mason received an undergraduate degree from Indiana University.
Deborah J. Andrews Presently, Deborah J. Andrews holds the position of Chief Financial Officer of STAAR Surgical Co. She is also on the board of BioTime, Inc. Ms. Andrews previously was Internal Auditor of Bourns, Inc., Vice President-Finance at STAAR Surgical AG and Auditor for KPMG Peat Marwick LLP. Ms. Andrews received an undergraduate degree from California State University-San Bernardino.
Samuel J. Gesten Presently, Samuel J. Gesten is Secretary & Chief Legal Officer for STAAR Surgical Co. Mr. Gesten is also on the board of Serica Technologies, Inc. and UCP of Orange County. In the past he held the position of Vice president & Deputy General Counsel at Thermo Fisher Scientific, Inc. and Executive Vice President & General Counsel of Allergan, Inc. Samuel J. Gesten received an undergraduate degree from Brandeis University and a graduate degree from Boston University School of Law.
Louis E. Silverman Louis E. Silverman is a businessperson who has been at the helm of 5 different companies and presently holds the position of Chairman at STAAR Surgical Co., Chairman & Chief Executive Officer at Advanced ICU Care, Inc. and Chairman for Comarco, Inc. He is also on the board of PatientPay, Inc. In his past career Mr. Silverman occupied the position of President & Chief Executive Officer of NextGen Healthcare, Inc., Chief Operating Officer at CorVel Corp., Chief Executive Officer-LifeComm Division at QUALCOMM, Inc. and Chief Executive Officer at Marina Medical Billing Services, Inc. He received an undergraduate degree from Amherst College and an MBA from Harvard Business School.
Stephen C. Farrell Stephen C. Farrell holds the position of Chief Executive Officer & Director at Convey Health Solutions, Inc. and Chief Executive Officer at United States Pharmaceutical Group LLC (a subsidiary of Convey Health Solutions, Inc.). He is also on the board of STAAR Surgical Co., BioTime, Inc. and Brewster Academy. In his past career he was President, COO, CFO & Chief Compliance Officer at PolyMedica Corp., Chief Financial Officer & Executive Vice President of Stream Global Services, Inc. and Vice President & Senior Manager at PricewaterhouseCoopers LLP. Mr. Farrell received an undergraduate degree from Harvard University and an MBA from the University of Virginia Darden School of Business.
William P. Wall William P. Wall is on the board of STAAR Surgical Co., Haynes International, Inc. and Capital International Ltd. (California) and Managing Member at Oq Partners LLC. In his past career Mr. Wall held the position of Managing Member at Ottauquechee Partners LLC, Associate for Ropes & Gray LLP, Partner at Andover Capital Advisors LP, Director & General Counsel at Nations Equipment Finance LLC, Managing Director at Fidelity Capital Investors, Inc., Director & General Counsel at Automile Holdings LLC, Director & General Counsel at Abrams Capital International Ltd. and General Counsel at Abrams Capital Management LLC. William P. Wall received an undergraduate degree from the University of Massachusetts and a graduate degree from Harvard University.
Jon K. Hayashida Jon K. Hayashida is Vice President-Medical Affairs & Global Clinical at STAAR Surgical Co. Dr. Hayashida previously was Vice President-Clinical & Medical Affairs at Bausch + Lomb, Inc., Vice President-Clinical Affairs at Transcend Medical, Inc., Vice President-Clinical Affairs at WaveTec Vision Systems, Inc., Vice President-Clinical Affairs at Refractec, Inc., Vice President-Global Clinical Affairs at CooperVision, Inc., Principal at Allergan, Inc., Principal at Jules Stein Eye Institute, Principal at The National Board of Medical Examiners, Inc. and Vice President-Programs & Services at Braille Institute of America, Inc. Dr. Hayashida received an undergraduate degree and a doctorate from the University of Southern California.
John C. Moore Currently, John C. Moore occupies the position of Chief Technical Officer at Tearsolutions LLC. Mr. Moore is also on the board of STAAR Surgical Co. In the past Mr. Moore was Chairman of Optovue, Inc., Chief Executive Officer at Notal Vision Ltd., Principal at Coherent, Inc., President & Chief Executive Officer for Laser Diagnostic Technologies, Inc., Principal at Carl Zeiss AG and Vice President at Alcon Laboratories, Inc. Mr. Moore received an undergraduate degree from the University of Rochester.
Hans-Martin Blickensdoerfer Presently, Hans-Martin Blickensdoerfer occupies the position of SVP-Commercial Operations, Europe & China at STAAR Surgical Co. In his past career Mr. Blickensdoerfer was Commercial Director-Europe, Middle East & Africa at Novartis AG, Vice President-Sales & Marketing at Milvella Ltd. and Area Sales Manager-Central & Eastern Europe at Bausch + Lomb, Inc. He received a graduate degree from the University of Mannheim.
Graydon Hansen Graydon Hansen is Senior Vice President-Global Operations at STAAR Surgical Co. In the past he held the position of Operations Director at Electro Energy, Inc.
Keith Holliday Keith Holliday holds the position of Chief Technology Officer at STAAR Surgical Co. In his past career Dr. Holliday held the position of Vice President-Research & Development for ReVision Optics, Inc., Director-Laser Technology at Advanced Medical Optics, Inc., Principal at AMO Manufacturing USA LLC and Principal at Swiss Federal Institute of Technology. He received an undergraduate degree from the University of St. Andrews and a doctorate from Australian National University.
Philippe Subrin Philippe Subrin is Vice President-ICL Manufacturing at STAAR Surgical Co. In the past he held the position of Manufacturing Manager at Bausch & Lomb France SAS and Vice President-Manufacturing at STAAR Surgical AG. Mr. Subrin received an undergraduate degree from the University of Lyon.
James E. Francese James E. Francese is SVP-Commercial Operations at STAAR Surgical Co. In the past Mr. Francese occupied the position of Vice President-Asia Pacific Region at Abbott Medical Optics, Inc. Mr. Francese received an undergraduate degree from Cornell University, a graduate degree from the University of Washington and an MBA from the University of Southern California.
Denise McEachern Denise McEachern is Head-Regulatory Affairs & Quality Assurance at STAAR Surgical Co. In her past career Ms. McEachern occupied the position of Vice President-Global Regulatory Affairs at Bausch + Lomb, Inc. She received a graduate degree from Concord Law School and an undergraduate degree from Washington College.
Graydon Hansen Graydon Hansen is Senior Vice President-Global Operations at STAAR Surgical Co. In the past he held the position of Operations Director at Electro Energy, Inc.
Surindra Mann Surindra Mann is VP-Global Financial Planning & Analysis at STAAR Surgical Co.
Scott D. Barnes Currently, Scott D. Barnes is Chief Medical Officer at STAAR Surgical Co. Dr. Barnes is also Chief Ophthalmology Services Officer at Womack Army Medical Center. He received an undergraduate degree from Wheaton College (Illinois) and a doctorate from Northwestern College (Illinois).
Brian Moore Currently, Brian Moore occupies the position of Head-Investor Relations of STAAR Surgical Co.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐